Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathwayKevin Guo, Hong Zhang|Oncotarget|2017Cited by 20
Opposing effects of systemic and pancreas-specific inhibition of BCKDK on pancreatic carcinogenesisMichael Noji, Kathryn E. Wellen, Christina Demetriadou et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0